CATHERINE LAI-HSU: Open Payments
NPI 1902395486 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,622 in 68 payments from 18 companies in 2025. Trend: 2023 $2,811 · 2024 $1,701 · 2025 $1,622
Food & beverage: $1,622
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $232 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $175 |
| Otsuka America Pharmaceutical, Inc. | 7 | $174 |
| Almatica Pharma LLC | 7 | $146 |
| Alkermes, Inc. | 6 | $141 |
| Neurocrine BioSciences, Inc. | 5 | $125 |
| E.R. Squibb & Sons, L.L.C. | 4 | $96 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Corium, LLC | 2 | $59 |
Products named: REXULTI, Auvelity, CAPLYTA, LOREEV XR, INGREZZA, COBENFY, LYBALVI, Jornay PM.
Industry payments across FL — which companies pay providers there.
